DV
Dividend Vision

BCRX — BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. (BCRX)

Total return is 49.8% over the past 32.4 years, 2807.3 points behind SPY at 2857.1%. Its deepest 1-year drawdown was 27.3%.

BCRX is a single healthcare stock rather than a diversified ETF, representing shares in BioCryst Pharmaceuticals, a company focused on the biopharmaceutical sector. As an individual equity security, it does not have a distribution rate, expense ratio, or fund-level characteristics typical of ETFs, and investors receive returns primarily through stock price appreciation rather than dividend distributions. This holding appeals to investors seeking direct equity exposure to a specific pharmaceutical company rather than those looking for diversified dividend income strategies.

BCRX key facts

Asset type
Stock
Asset class
Equity
Inception date
03/04/1994
Distribution frequency
None
Last close
$9.74
Market cap
$2,488,911,872
Average volume
3819700.0
Beta
0.554
Payout ratio
0.0
Forward P/E
28.9017
EPS
$-1.40